Sentinel Reports The Aurora Sentinel
Researchers from the University of Colorado Cancer Center are set to start human trials for a new cervical cancer vaccine in coming months, according to officials from the college.
According to Bob Garcea, a UCCC researcher and a professor at the University of Colorado’s Boulder campus, researchers could start testing the new vaccine on humans within the year.
Garcea said the new vaccine could serve as an affordable option in countries like India, where access to existing medications are too expensive for most women. Funding for the research came in part from a National Cancer Institute grant from 2002 and a $3.4 million grant in 2005 from the Bill and Melinda Gates Foundation. An $11.5-million grant from the National Cancer Institute will fund the trials.